Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.N)

TEVA.N on New York Stock Exchange

7.22USD
11:04am EDT
Change (% chg)

$-0.23 (-3.09%)
Prev Close
$7.45
Open
$7.48
Day's High
$7.54
Day's Low
$7.13
Volume
1,051,813
Avg. Vol
3,756,295
52-wk High
$25.13
52-wk Low
$6.07

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Sol Barer

70 2017 Independent Chairman of the Board

Kaare Schultz

57 2017 President, Chief Executive Officer, Director

Michael McClellan

48 2017 Chief Financial Officer, Executive Vice President

Iris Beck-Codner

52 2017 Executive Vice President - Global Brand & Communications

Richard Daniell

51 2017 Executive Vice President - European Commercial